Ameritas Investment Partners, Inc. - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,871
-30.3%
15,0000.0%0.00%
Q4 2022$2,685
+34.2%
15,0000.0%0.00%
Q3 2022$2,000
-84.6%
15,0000.0%0.00%
-100.0%
Q2 2022$13,000
-31.6%
15,0000.0%0.00%0.0%
Q1 2022$19,000
-34.5%
15,0000.0%0.00%0.0%
Q4 2021$29,000
-29.3%
15,0000.0%0.00%0.0%
Q3 2021$41,000
-12.8%
15,0000.0%0.00%
-50.0%
Q2 2021$47,00015,0000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 5,095,354$5250.06%
TKG Advisors, LLC 134,860$13,8910.01%
GPS Wealth Strategies Group, LLC 253,205$25,3210.01%
Performa Ltd (US), LLC 70,000$7,2100.00%
Genesee Capital Advisors, LLC 19,860$2,0460.00%
Garden State Investment Advisory Services LLC 30,000$3,0900.00%
MAI Capital Management 617,733$63,6260.00%
Twin Lakes Capital Management, LLC 12,500$1,2880.00%
DRIVE WEALTH MANAGEMENT, LLC 10,000$1,0300.00%
Boyd Wealth Management, LLC 12,180$1,2550.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders